A comprehensive review published in the British medical journal BMJ has found no clear evidence linking the use of paracetamol during pregnancy to autism or ADHD in children. This conclusion comes in response to repeated claims by former U.S. President Donald Trump, who asserted that the common painkiller could increase autism rates. Trump’s comments, urging pregnant women to avoid paracetamol, sparked widespread criticism from the medical community, who warned that such statements could deter women from using one of the safest pain relief options available. The World Health Organisation has also emphasized the lack of robust evidence supporting such a link. The umbrella review, led by a UK-based team of researchers, analyzed all existing scientific studies on the topic and found that previous research suggesting a connection was of ‘low to critically low’ quality. These studies failed to account for confounding factors, such as genetic predispositions, and could not establish a causal mechanism. The review also highlighted the historical underinvestment in women’s health research and called for more rigorous studies. Experts praised the findings, with Professor Dimitrios Siassakos of University College London stating that the review ‘confirms what experts around the globe have been saying.’ Steven Kapp of the University of Portsmouth, an autistic researcher with ADHD, emphasized the importance of improving life for neurodivergent individuals rather than attempting to prevent neurodivergence. Beyond paracetamol, Trump and his vaccine-skeptic Health Secretary Robert F. Kennedy Jr. have made unfounded claims about an autism ‘epidemic,’ which experts attribute to improved diagnostic methods and increased awareness.